STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Synergy CHC Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Jaime Fickett, identified as Chief Financial Officer of Synergy CHC Corp. (SNYR), reported a grant of a stock option on 09/18/2025. The option covers 150,000 shares of common stock with an exercise price of $2.38 per share and an expiration date shown as 09/18/2030. The filing states the full award is held directly by the reporting person following the transaction. The option vests one-third on the first anniversary of the grant and the remaining two-thirds in equal monthly installments over the subsequent 24 months, subject to continued service. The form was signed by an attorney-in-fact on 09/22/2025.

Positive
  • Time-based vesting aligns the CFO's incentives with multi-year shareholder value creation
  • Disclosure filed promptly with a signature by attorney-in-fact, meeting reporting requirements
Negative
  • Potential dilution of 150,000 shares if the option is exercised
  • No performance-based conditions are disclosed; vesting is solely time-based

Insights

TL;DR: Routine executive equity award to CFO, standard multi-year vesting and five-year term.

The filing documents a non-derivative equity grant in the form of a stock option for 150,000 shares at a $2.38 exercise price, expiring 09/18/2030. Vesting is time-based: one-third after one year and the remainder monthly over 24 months. For investors, this is a customary retention and incentive tool rather than an immediate cash impact. The award increases potential future dilution if exercised, but the grant itself is a standard corporate governance practice for senior management.

TL;DR: Compensation action aligns CFO incentives with shareholders but creates future dilution if fully exercised.

The reported option is direct beneficial ownership and uses a multi-year vesting schedule tied to continued service, which is consistent with aligning executive performance and retention goals. The five-year contractual life to 09/18/2030 provides a window for potential alignment with long-term value creation. The filing contains clear vesting terms and shows timely disclosure by the issuer, meeting routine Section 16 reporting expectations.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fickett Jaime

(Last) (First) (Middle)
C/O SYNERGY CHC CORP.
865 SPRING STREET

(Street)
WESTBROOK ME 04092

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $2.38 09/18/2025 A 150,000 (1) 09/18/2030 Common Stock, par value $0.00001 per share 150,000 $0 150,000 D
Explanation of Responses:
1. One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 09/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jaime Fickett report in the Form 4 for SNYR?

The filing reports a grant of a stock option to purchase 150,000 common shares on 09/18/2025 at an exercise price of $2.38, expiring 09/18/2030.

What are the vesting terms of the option reported on Form 4?

The option vests one-third on the first anniversary of the grant date and the remaining two-thirds in equal monthly installments over the following 24 months, subject to continued service.

Is the reported ownership direct or indirect?

The filing shows the 150,000 option and underlying shares are held directly by the reporting person following the transaction.

Does the Form 4 show the exercise price and expiration date?

Yes. The exercise price is $2.38 per share and the expiration date is listed as 09/18/2030.

Who signed the Form 4 and when?

The form is signed by Nelson Mullins Riley & Scarborough LLP, attorney-in-fact, with a signature date of 09/22/2025.
Synergy Chc Corp

NASDAQ:SNYR

SNYR Rankings

SNYR Latest News

SNYR Latest SEC Filings

SNYR Stock Data

22.22M
4.84M
56.75%
3.82%
1.06%
Medical Distribution
Medicinal Chemicals & Botanical Products
Link
United States
WESTBROOK